Concepedia

Volodymyr Karpa

VK

Statistics

Publications

11

Citations

485

H-Index

10

Active since

2007

Affiliations

The Ohio State University(Current)

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute

Cancer Genetics (United States)

Wright State University

Nationwide Children's Hospital

Volodymyr Karpa is an author at The Ohio State University specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

2007–2019

11

Publications

11

MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor

Sara E. Martin del Campo, Nicholas Latchana, Kala Levine et al. · PLoS ONE · 2015 · 105 citations · Full text

, , +15

IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-γ Production

Alena Cristina Jaime‐Ramirez, Bethany L. Mundy-Bosse, SriVidya Kondadasula et al. · The Journal of Immunology · 2011 · 98 citations · Full text

, , +17

miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions

Valerie P. Grignol, Ene T. Fairchild, Jason M. Zimmerer et al. · British Journal of Cancer · 2011 · 76 citations · Full text

, , +17

IFN-α-Induced Signal Transduction, Gene Expression, and Antitumor Activity of Immune Effector Cells Are Negatively Regulated by Suppressor of Cytokine Signaling Proteins

Jason M. Zimmerer, Gregory B. Lesinski, Sri Vidya Kondadasula et al. · The Journal of Immunology · 2007 · 64 citations · Full text

, , +17

A phase I study of recombinant (r) vaccinia-CEA(6D)-TRICOM and rFowlpox-CEA(6D)-TRICOM vaccines with GM-CSF and IFN-α-2b in patients with CEA-expressing carcinomas

Megan Duggan, Caroline Jochéms, Renee N. Donahue et al. · Cancer Immunology Immunotherapy · 2016 · 35 citations · Full text

, , +14

1–5 of 11